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Capsule: This paper addresses a model for accumulation of organic compounds by 36 
mother and breast-fed infant, applicable for exposure assessment within larger 37 
frameworks.  38 
 39 
 40 
Abstract 41 
 42 
Bioaccumulation of persistent organic pollutants (POPs) leads to high levels in human 43 
milk and high doses of POPs for nursing infants. This is currently not considered in 44 
chemical risk assessment. A coupled model for bioaccumulation of organic chemicals in 45 
breastfeeding mother and nursing infant was developed and tested for a series of organic 46 
compounds. The bioaccumulation factors (BAF) in mother, breast milk and child were 47 
predicted to vary with log Kow and, for volatile compounds, with Kaw and concentration 48 
in air. The concentrations of POPs in the infant body increase the first half year to about 49 
factor 3 above mother and decline thereafter to lower levels. The predicted results are 50 
close to empirical data and to an empirical regression. The new mother-child model is 51 
compact due to its easy structure and the analytical matrix solution. It could be added to 52 
existing exposure and risk assessment systems, such as EUSES.  53 
 54 
 55 
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1 Introduction  59 
 60 
Persistent organic pollutants (POPs) are "chemicals that remain intact in the environment 61 
for long periods, become widely distributed geographically, accumulate in the fatty tissue 62 
of living organisms, and are toxic to humans and wildlife" (UNEP 2007). POPs, such as 63 
polychlorinated dibenzodioxins and -furans (PCDD/F), polychlorinated biphenyls (PCB) 64 
and chloroorganic pesticides, have been detected in human milk samples all over the 65 
world (Rogan et al. 1986, Schecter et al. 1996, Filser et al. 1997, Raab et al. 2007, Shen 66 
et al. 2007, Wittsiepe et al. 2007, Tanabe and Kunisue 2007). This raised considerable 67 
concern about adverse health effects on nursing infants (Harrison 2001, CEHAPE 2004, 68 
US EPA 2006).  69 
 70 
The uptake of POPs, such as PCDD/F, by adults is mainly via food ingestion (Travis and 71 
Hattemeyer-Frey 1991). The uptake by nursing infants via breast milk has been reported 72 
to be higher than by adults via diet, for some POPs at levels above the acceptable daily 73 
intake (Dahl et al. 1995, Kreuzer et al. 1997, Schade and Heinzow 1998, BGVV 2000, 74 
Tanabe and Kunisue 2007). POPs may accumulate for a longer period in the body of the 75 
mother and then be transferred to the nursing infant via mother's milk. Travis et al. (1988) 76 
developed empirical relations for the accumulation of chemicals in human adipose tissue 77 
and human milk. The regressions are based on 12 (tissue) or 6 (milk) organic chemicals 78 
with a log KOW between 1.32 and 6.50 (tissue) or 5.16 to 6.50 (milk). The 79 
bioaccumulation factors Bf (tissue) and Bm (milk) were defined as  80 
 81 
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         Concentration of organic in adipose tissue (mg/kg lipid) 82 
Bf =    83 
                     Average daily intake of organic (mg/d) 84 
 85 
 86 
          Concentration of organic in breast milk (mg/kg lipid) 87 
Bm =    88 
                   Average daily intake of organic (mg/d) 89 
 90 
Travis et al. (1988) related these bioaccumulation factors to the log KOW of the 91 
substances.  92 
 93 
Bf = 2.0 x 10-4 Kow1.05     


kg
d    (n=12, r=0.98)  94 
Bm = 9.8 x 10-5 Kow1.14  


kg
d    (n=6, r=0.97) 95 
 96 
Besides this empirical approach, several mathematical model approaches exist to predict 97 
human tissue concentrations after uptake, e.g. the models prepared by Kreuzer et al. 98 
(1997) or Filser et al. (1997) and Maruyama et al. (2003) for PCDD/F. Accumulation in 99 
the food chain with subsequent accumulation in humans was addressed by Czub and 100 
McLachlan (2004a,b). To summarize, compound-specific models, comprehensive 101 
numerical models and also easy empirical models for the prediction of the accumulation 102 
of POPs in humans are available.  103 
 104 
However, what lacks is a model predicting accumulation of POPs or other compounds in 105 
breastfeeding mother and nursing infant after uptake of chemicals via diet or other 106 
relevant sources by mother, which is compact enough to be combined with other models 107 
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and estimation routines, e.g., for chemical safety assessment tools such as EUSES (EC 108 
1996).  109 
 110 
"Traditional risk assessment approaches and environmental health policies have focused 111 
mainly on adults and adult exposure patterns, utilizing data from adult humans or adult 112 
animals" (CEHAPE 2004). Indeed, current chemical risk assessment in the EU (EC 2003) 113 
considers only grown-ups (70 kg bodyweight). An additional focus on children and in 114 
particular nursing infants, which are one trophic level higher and are eventually also more 115 
sensitive to chemicals, requires a compact exposure estimation method that can run with 116 
a minimum data set.  117 
 118 
This paper addresses the development, parameterization, sensitivity analysis, validation 119 
and application of a coupled model for accumulation of organic compounds by nursing 120 
mother and child. The coupled differential equations were solved analytically. The model 121 
was tested with 2,3,7,8-TCDD and compared to empirical data for 11 other compounds 122 
collected by Travis et al. (1988).  123 
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2 Methods  124 
 125 
2.1 Model  Development  126 
Figure 1 gives an overview of the system considered by the model. The human body is 127 
considered as a flux-through system. The input of chemical occurs via diet (mother) or 128 
milk (child) and inhalation (both). Inside the body, phase equilibrium is assumed. The 129 
compound is eliminated from the body by exhalation and excretion (both together are 130 
named "outflux"), by metabolism and, in case of the nursing mother, with breast milk.  131 
 132 
<Figure 1>  133 
 134 
Mother before birth of the child 135 
The input of chemical into the mother is independent of the concentration in her body, 136 
CH, while the output is proportionally related to it. This yields a linear differential 137 
equation for the mass balance of the form  138 
 139 
mkI
dt
dm           (1) 140 
 141 
where m [mg] is the mass of chemical in the human body, I  [mg d-1] is the sum of daily 142 
uptake of chemical and k [d-1] is the loss rate constant.  143 
 144 
The input I can be derived from measurements or exposure assessments. The loss rate 145 
constant k is calculated from the flux of chemical out of the body.  146 
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 147 
The human body is considered as composed of the phases lipids and water. Lipids were 148 
assumed to dissolve the chemical similar to octanol. The phase equilibrium between 149 
concentration in human body, CH [mg kg-1], and concentration in water, CW [mg L-1], is  150 
 151 
OW
L
H
H
W
H
HW K
LW
C
CK    


kg
L       (2) 152 
 153 
where KHW is the partition coefficient human body to water [L kg-1], WH is the water 154 
content [L kg-1] and LH is the lipid content of the human body [kg kg-1], L is the density 155 
of lipids [kg L-1] and KOW [L L-1] is the partition coefficient between octanol and water.  156 
 157 
The change of chemical mass in time due to outflux of chemical from the body dmF/dt 158 
[mg d-1] is the sum of outflux with water, lipid and air 159 
 160 
FAFALFLWFW
F CFCFCFCF
dt
dm  ,,,   


d
mg        (3) 161 
 162 
where FW is the outflux of water [L d-1], FL is the outflux of lipids [kg d-1] (with feces) 163 
and FA is the outflux of air [L d-1] (exhalation). CF,W [mg L-1], CF,L [mg kg-1] and CF,A [mg 164 
L-1] are the concentrations in the water, lipid and gas fraction of the outflux; CF [mg kg-1] 165 
is the weighted average concentration in the outflux. The total material outflux F [kg d-1] 166 
is the sum of the outfluxes of water, lipids and air, 167 
 168 
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AALWW FFFF     


d
kg       (4) 169 
 170 
Using the assumption of phase equilibrium we can rewrite to  171 
 172 
WFAWAWFOWLWFWF CKfFCKfFCfFCF ,,,    (5) 173 
 174 
where KAW is the partition coefficient [L L-1] between air and water (also known as 175 
dimensionless Henry's Law constant), and f are the flux fractions [L/d : kg/d] of water W, 176 
lipids L and air A of the total flux F,  177 
 178 
F
Ff WW  , F
Ff LLL
  and 
F
Ff AA   


kg
L      (6) 179 
 180 
The average concentration of chemical in the outflux, CF, is then  181 
 182 
WFAWAWFOWLWFWF CKfCKfCfC ,,,      (7) 183 
 184 
Note that for phase equilibrium, CF,W (concentration in aqueous phase of outflux) equals 185 
CW (concentration in aqueous phase of human body), and thus we derive 186 
 187 
AWAOWLW
W
F
FW KfKffC
CK   


kg
L      (8) 188 
 189 
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where KFW [L kg-1] is the partition coefficient between outflux [kg d-1] and water [L d-1]. 190 
Then, the partition coefficient between human body and outflux, KHF [kg/kg], is  191 
 192 
FW
HW
F
H
HF K
K
C
CK      


kg
kg      (9) 193 
 194 
where CH and CF are the concentrations [mg kg-1] in human body and outflux in phase 195 
equilibrium. It follows for the loss rate constant k [d-1] in eq. 1, which is the sum of the 196 
losses by outflux and by metabolism or degradation with first-order kdeg [d-1]  197 
 198 
degkKM
Fk
HFH
      


d
1        (10) 199 
 200 
where MH [kg] is the bodyweight. The analytical solution of equation (1) for the chemical 201 
mass m [mg] in human body at time t is  202 
 203 
)1()( 0
ktkt e
k
Iemtm           (11) 204 
 205 
which gives in steady-state (t →∞)  206 
 207 
k
Im )(           (12) 208 
 209 
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Concentrations CH [mg/kg] in the human body were derived from CH=m/MH, assuming a 210 
constant bodyweight MH 211 
 212 
HH
H Mk
I
M
mC 
 )()(    


kg
mg      (13) 213 
 214 
This solution was used to calculate the concentration of chemical in the woman before 215 
birth of the child (and before pregnancy, the bodyweight is constant at 60 kg). 216 
 217 
Nursing mother with child  218 
In this scenario, the mother gives birth to a child and nurses the infant. Equations for the 219 
mother were modified, and new equations for breast milk and nursing child were 220 
introduced. 221 
 222 
Mother. Nursing changes the outflux from the mother. Milk consists in the model of 223 
water and lipids. The flux of milk FM [kg d-1] was added to the outflux F in equation (4) 224 
 225 
MMMWMAALWW FLFWFFFF     


d
kg   (14) 226 
 227 
where WM [L kg-1] is the water content and LM [kg kg-1] is the lipid content of human 228 
milk. Fractions of outflux [L kg-1]  fW, fL and fA were recalculated for the case of nursing.  229 
 230 
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F
FWFf MMWW
 , 
L
MML
L F
FLFf 
  and 
F
Ff AA     


kg
L   (15) 231 
 232 
The other equations (eqs. 1,2, 8-13) were applied without changes, but the new values of 233 
F and f were entered.  234 
 235 
Milk. With breast milk, chemical is lost from the mother and transferred to the baby 236 
(Schecter et al. 1996). To calculate the concentration of chemical in milk, phase 237 
equilibrium between milk and mother was assumed. The concentration in milk CM [mg 238 
kg-1] is   239 
 240 
HMHM CKC     


kg
mg       (16) 241 
 242 
where KMH [kg kg-1] is the partition coefficient between milk and human. The partition 243 
coefficient milk to water KMW [L kg-1] is  244 
 245 
OW
L
M
M
W
M
MW K
LW
C
CK     


kg
L      (17) 246 
 247 
The partition coefficient between milk and human body KMH [kg/kg] is then 248 
 249 
HW
MW
H
M
MH K
K
C
CK      


kg
kg      (18) 250 
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 251 
Child. The breast-fed infant can take up chemicals by breast milk and by inhalation. 252 
Breathing is external input to the child, AAC CFI  , where FA [here: m3 d-1] is the flux 253 
of inhaled air and CA [mg m-3] is the concentration of chemical in air. Loss of chemical 254 
occurs via outflux and by metabolic elimination with first-order rate constant kdeg [d-1]. 255 
The mass balance for the child is  256 
 257 
CCFMMC
C mkFCFCI
dt
dm  deg       (19) 258 
 259 
where CM [mg kg-1] denotes the concentration in breast milk, FM [kg d-1] is the flux of 260 
milk from mother to child, CF [mg kg-1] is the concentration in the outflux of the child 261 
and FC  [kg d-1] is the outflux from the child.  262 
 263 
Using the partition coefficients, the equation can be rewritten to  264 
 265 
CC
CCF
C
H
H
M
MHC
C mkm
MK
F
m
M
FKI
dt
dm  deg   


d
mg   (20) 266 
 267 
where mH [mg] is the chemical mass in mother (human H), mC [mg] is the chemical mass 268 
in the child, KCF [kg kg-1] is the partition coefficient between child and outflux and MC 269 
[kg] is the body mass of the child. The phase equilibrium between child body (index C) 270 
and water (index W) is  271 
 272 
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OW
L
C
C
W
C
CW K
LW
C
CK       


kg
L     (21) 273 
 274 
where KCW [L kg-1] is the partition coefficient child body to water, C is the equilibrium 275 
concentration in child, index C [mg kg-1], or water, index W [mg L-1], WC [L kg-1] is the 276 
water content and LC [kg kg-1] is the lipid content of the child body. The initial 277 
concentration in the child CC(0) [mg kg-1] was calculated from phase equilibrium to 278 
mother 279 
 280 
H
HW
CW
C CK
KC )0(          (22) 281 
 282 
The outflux FC [kg d-1] from the child was summed up, as was done for the outflux from 283 
the mother: 284 
 285 
AALWWC FFFF          (23) 286 
  287 
where indeces W, L and A indicate water, lipid and air. Again, the flux fractions were 288 
used to calculate the phase equilibrium between outflux and water, KFW :  289 
 290 
AWAOWLW
W
F
FW KfKffC
CK     


kg
L    (24) 291 
 292 
The partition coefficient between child body and outflux, KCF [kg/kg], is  293 
 14
 294 
FW
CW
F
C
CF K
K
C
CK      


kg
kg      (25) 295 
 296 
2.2 Matrix Solution  297 
The differential equations of mother and child are coupled and were treated as a linear 298 
2×2 matrix system of the form  299 
 300 
1212111
1 Imama
dt
dm          (26) 301 
2222121
2 Imama
dt
dm          (27) 302 
 303 
Matrix element 1 is the mother. The matrix constant a11 [d-1] is the sum of all loss 304 
processes from the mother and is identical with the negative loss rate k (eq. 10). The 305 
matrix constant a12 [d-1] is what mother receives from the child and is zero (therefore, the 306 
equation for chemical mass in mother can be solved independently of that for the child, 307 
eqs. 1 and 11). Input I1 [mg d-1] is the sum of all input to mother.  308 
 309 
Matrix element 2 is the nursed child. The matrix constant a21 [d-1] describes the transfer 310 
via milk from mother to child, a21=KMH×FM /MH. The matrix constant a22 [d-1] describes 311 
all losses of chemical from the child, a22 = –FC /(KCF×MC )–kdeg. Input I2 includes all 312 
chemical input independent from the mother, i.e. via inhalation, I2=FA×CA. A standard 313 
solution for this system of differential equations exists for the case of constant rates and 314 
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inputs (Nazaroff and Alvarez-Cohen 2001). Concentrations [mg/kg] were derived by 315 
dividing the chemical mass [mg] by the bodyweight [kg]. 316 
 317 
2.3 Parameterization of the Model  318 
Input data (Table 1) was selected from several sources, preferably from existing models 319 
(Kreuzer et al. 1997, Czub and McLachlan 2004b), in order to allow a comparison of the 320 
results. The application of the steady-state solution (eqs. 12, 13) for the mother before the 321 
birth of her child avoids the need to chose an appropriate initial mass m0 for the first 322 
generation. The 95%-steady-state is reached for latest t=18 years for all chemicals with 323 
the default parameterization.  324 
 325 
The total daily uptake I  [mg d-1] was calculated as the sum of uptake via diet iD [mg/d] 326 
and inhalation of air: 327 
 328 
AAD CFiI   


d
mg         (28) 329 
 330 
For the breast-fed baby, iD is 0.  331 
 332 
Outflux of lipids was assumed to be 10% of lipids in the diet. With 70 g d-1 as average 333 
lipid ingestion, 0.007 kg d-1 outflux of lipids results. For the baby, 0.0045 kg d-1 (1/10 of 334 
influx of lipids with milk) was used. Table 1 lists the input data chosen as default for the 335 
model and used in the following simulations. 336 
 337 
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To calculate concentrations in the body of the child during the simulation period, the 338 
respective bodyweight was used, to account for growth effects. The bodyweight of the 339 
child with age (in years) was approximated by a second-order polynom fitted to growth 340 
data for girls in Germany (Hesse et al. 1997) (eq. 29)  341 
 342 
54.376.3053.0 2  ageagebw    (n=36, R2=0.98) (29) 343 
 344 
<Table 1> 345 
 346 
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3 Results  347 
 348 
3.1 Example Simulation TCDD 349 
To illustrate the general behaviour of the model, an example simulation with 2,3,7,8-350 
tetrachlordibenzo-p-dioxin (TCDD) was performed. TCDD is a highly toxic, persistent 351 
lipophilic (log KOW 6.76) and semivolatile (KAW 0.0015) compound (Rippen 1991). The 352 
concentration of TCDD in air was set to 4 fg m-3 (background concentration in Southern 353 
Germany, McLachlan 1992). Ingestion of TCDD by the mother with diet was 25 pg d-1 354 
(Kreuzer et al. 1997). Figure 2 shows the simulated concentration of TCDD in lipids for 355 
mother and child over a three-years period. The starting concentration of the mother [3.6 356 
ng kg-1 lipid] is the steady-state concentration (eq. 13). For t>0, the matrix solution was 357 
applied. For t>0, the concentration of TCDD in mother decreases exponentially and falls 358 
to 63% of the initial concentration after 1/2 year and to 42% after 1 year of nursing. The 359 
initial concentration in the infant [3.6 ng kg-1 lipid] is in equilibrium to mother. It steeply 360 
increases to 12.3 ng kg-1 lipids after ½ year. Hereafter, it falls, due to depletion of the 361 
mother's body burden and growth dilution, to 8.8 ng kg-1 lipids after 1 year and to 1.73 ng 362 
kg-1 lipid after 3 years (of course, 3 years nursing is rare). The concentration in lipids of 363 
milk is identical to that in lipids of the mother body and was not plotted. During the 364 
period of nursing, the loss of TCDD from mother with milk is higher than the daily 365 
intake, which is the reason for the depletion of TCDD from the body of the mother.  366 
Figure 3 shows the ratio of the TCDD-dose taken up by the infant (per kg bw) divided by 367 
the dose taken up by the mother (25 pg d-1 =0.42 pg kg-1 bw d-1). The ratio is initially 110 368 
and falls later to 45 (t=1/2a), 22 (t=1a) and 4.5 (t=3a). The dose ratio is much higher than 369 
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the concentration ratio (Figure 2). Uptake of TCDD with air is neither for mother 370 
(inhalation 11 m3 per day, uptake 44 fg TCDD per day) nor infant (inhalation 4.5 m3 per 371 
day, uptake 18 fg TCDD per day) of relevance. The maximum concentration ratio child 372 
to mother is reached after t=1/2a. The concentration in the child is maximally 3.4times 373 
that in mother before birth and falls to 2.5times (t=1a) and to 0.48times (t=3a), due to 374 
rapid elimination and growth dilution. The calculated elimination half-time (ln 2 divide 375 
by rate constant k) of TCDD from the body is 4.6 years for the mother before birth, 0.6 376 
years for the nursing mother and only 0.34 years for the infant. 377 
These simulation results can be confronted to empirical data (Kreuzer et al. 1997, Filser 378 
et al. 1997). Measured concentrations of TCDD in lipids of adipose tissue and blood for 379 
adults in Germany early 1990ies range from <0.1 ng kg-1 lipid  to 16 ng kg-1 lipids, with 380 
an average background level of 3 ng kg-1 lipids (Filser et al. 1997). Concentrations in 381 
breast milk vary between 1 and 3.9 ng kg-1 lipids, decreasing during the period of 382 
nursing, with an average of about 2 ng kg-1 lipids. TCDD-concentrations in stillborn 383 
range from of 1.3-2.1 ng/kg lipids. Concentrations of TCDD in lipids of adipose tissue, 384 
faeces and blood of infants did not differ much and ranged from <0.2 to 7.3 ng kg-1 lipids. 385 
TCDD levels in adipose tissue of 20 breast-fed infants aged between 0 and 44 weeks 386 
ranged from 0.16 to 4.1 ng kg-1 tissue and were higher than that of non-breast-fed 387 
children (0.16-0.76 ng kg-1 lipids) (Kreuzer et al. 1997). Predicted half-life of TCDD in 388 
infants was short (0.42 years), and increased to about 10 years for adults between 40 and 389 
60 years of age. These results are throughout close to the outcome of the simulations with 390 
the mother-child model, without any conflicting results.  391 
<Figure 2> <Figure 3>  392 
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4 Discussion  393 
 394 
4.1 Comparison of Regression and Mother-Child Model 395 
The regression of Travis et al. (1988) uses only one physico-chemical parameter, the 396 
KOW, while the mother-child model requires KOW and KAW. The bioaccumulation factors 397 
(BAF), related to concentration in lipids, derived from model and regression were 398 
compared. The concentration in air was set to 0. The steady-state BAF of mother at birth 399 
of the child (t=0) and the BAF milk after t=½ year were plotted in Figure 4. The BAF for 400 
mother and milk are practically identical, except for very hydrophilic compounds (the 401 
relation to lipids gives artificially higher concentrations for milk if compounds do not 402 
partition into lipids). The model BAF differ more than two orders of amount with low 403 
(10-9) or high (0.1) KAW except for high log KOW, because volatile compounds are rapidly 404 
lost from the body via exhalation. Within its regression range (log KOW 1.32 to 6.50), the 405 
regression gives similar results as the model with high KAW, probably because the less 406 
lipophilic compounds in the training set of the regression were all solvents with high KAW 407 
(Table 2). With increasing lipophilicity, the BAF predicted by the mother-child model 408 
reach a plateau (mother at t=0: BAF is 143 [d kg-1 lipid], milk at t=0.5 years: BAF is 90 409 
[d kg-1 lipid]), while the BAF derived by the regression increase unlimited with KOW. This 410 
is unrealistic, except for short time-periods, as the loss of super-lipophilic compounds via 411 
milk would be several orders of amount higher than the daily intake. The daily intake (1 412 
mg d-1) is balanced at a BAF milk (4.5% lipids) of 22 [d kg-1 lipid]. The regression gives 413 
a BAF=22 [d kg-1 lipid] with log KOW =4.7, but higher BAF for all log KOW above that 414 
value. Contrary, the steady-state (t=∞) BAF milk predicted by the mother-child model for 415 
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compounds with log KOW > 4.7 is constant at 19 [d kg-1 lipid]. In the initial period of 416 
nursing, the BAF milk is above steady-state, therefore, mother is depleted from POPs by 417 
nursing (Fig. 2).  418 
 419 
<Figure 4> 420 
 421 
4.2 Uptake via inhalation compared to uptake via food 422 
 423 
The impact of exhalation on BAF of hydrophilic to medium lipophilic compounds (log 424 
KOW < 5) is evident from Figure 4: fugitive compounds with high KAW show much lower 425 
bioaccumulation, due to this process. On the other hand, the KAW may also impact the 426 
uptake by inhalation. Basically, this uptake is calculated from the product of 427 
concentration in air and inhalation (eq. 28). Under certain conditions, such as ubiquitous 428 
background distribution of persistent compounds, we may assume that the concentrations 429 
in diet and air are near phase equilibrium. Using the formalism of section 2.1, the 430 
equilibrium ratio KDA [m3 kg-1] between concentration in diet CD [mg kg-1] and in air CA 431 
[mg L-1] is  432 
 433 
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L      (30) 434 
 435 
where WD is the water content [kg kg-1] and LD is the lipid content [kg kg-1] of the diet.  436 
 437 
The relation between the input data iD (uptake of chemical with diet, mg d-1) and CD is  438 
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 439 
DDD FCi            (31) 440 
 441 
where FD is the daily dietary consumption [kg d-1]. Thus, the equilibrium concentration in 442 
air CA,eq [mg L-1] is  443 
 444 
DDA
D
eqA FK
iC ,          (32) 445 
 446 
The dose via inhalation iA [mg d-1] is subsequently  447 
 448 
eqAAA CFi ,          (33) 449 
 450 
where FA is the inhalation of air [mother 11 m3 d-1 and child 4.5 m3 d-1]. 451 
 452 
A typical diet of an adult Danish female (FD) contains 60 g lipids and 2 L water, hereof 453 
1.4 L drinking water. Using these numbers, the ratio of uptake via air to uptake via diet, 454 
assuming phase equilibrium between air and food (including water), was calculated.  455 
 456 
Figure 5 shows that the relevance of inhalation as uptake pathway for chemicals into the 457 
human body depends much on the value of the partition coefficient air to water KAW. For 458 
non-volatile compounds (low KAW, 10-6 L L-1), inhalation is not relevant at all. With very 459 
low KAW (10-9 L L-1), the ratio of uptake with inhalation versus uptake with diet is never 460 
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above 1 : 100 000 (not shown). On the other hand, inhalation is the dominant way of 461 
entry into the body for volatile compounds (high KAW, 0.1 L L-1) with up to log KOW 4. 462 
With moderate KAW (10-3 L L-1 in Fig. 5), the relative importance of inhalation for the 463 
body burden decreases, but it is still higher than uptake by diet for the less lipophilic 464 
compounds (log KOW ≤ 2). For lipophilic compounds (log KOW > 5), which have the 465 
highest bioaccumulation, uptake by inhalation is generally not of much relevance. 466 
Compared to the mother, uptake via inhalation has similar (hydrophilic compounds) or 467 
lower importance (lipophilic compounds) for the child.  468 
 469 
Note that these calculations were done for the rare case of near-equilibrium conditions. In 470 
real life, many individuals live in urban centers, while the agricultural production is in 471 
remote rural areas. It may be expected that the air pollution is higher in the cities, in 472 
particular when additional indoor sources of pollutants are present. Furthermore, 473 
lipophilic compounds may be strongly adsorbed to particles, which are inhaled 474 
simultaneously with air. Thus, these conclusions are surely not of general validity, and 475 
the relative importance of inhalation for the uptake of pollutants may be higher in real life 476 
than expected from the calculations displayed in Fig. 5.  477 
 478 
<Figure 5> 479 
 480 
4.3 Validation Against Empirical Data  481 
To derive their regressions for bioaccumulation in adipose tissue and breast milk, Travis 482 
et al. (1988) collected twelve bioaccumulation factors (BAF) for human adipose tissue 483 
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and six BAF for breast milk from literature and pharmacokinetic models. The model was 484 
tested against these data. Additionally, BAF for TCDD were calculated from data in 485 
Kreuzer et al. (1997). The concentrations are related to lipid content. Log KOW-values 486 
given in the original reference (Travis et al. 1988) were used, except for TCDD (Rippen 487 
1991) (Table 2). One compound, pentachlorophenol, had to be excluded from the analysis 488 
because it is not a neutral compound but a weak acid (Rippen 1990). The uptake of weak 489 
electrolytes into living cells follows principles which are not covered by the model 490 
(Trapp 2004).  491 
 492 
<Table 2>  493 
 494 
In order to reproduce the experimental conditions under which empirical BAF were 495 
derived, concentration in air was set to zero. Figure 6 shows the measured BAF for 496 
human adipose tissue of the 12 organic compounds, the results from the regression by 497 
Travis et al. (1988) and the model outcome for mother before birth at steady-state. The 498 
measured BAF range from 0.013 (TCE) to 724 (DDE) and are lowest for the volatile 499 
compounds with low log KOW. Naturally, the regression predicts this range, and its results 500 
are generally less than factor 5 from the measurements, except for TCDD (over-predicted 501 
factor 21), which is out of the regression range. The model simulations, too, are close to 502 
the measured data. The results differ maximally factor 7 (dieldrin). The averaged ratio 503 
between predicted and measured BAF is 1.54 for the regression (3.15, including TCDD) 504 
and 2.0 for the model (including TCDD).  505 
 506 
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Figure 7 shows the measured BAF for human milk of seven organic compounds. The 507 
measured BAF range from 43 (dieldrin) to 1660 (PCB). The regression results are quite 508 
close to the measured BAF, except for TCDD. To derive the BAF, averaged values from 509 
milk samples in the period between birth and up to 18 month after birth have been used 510 
(Rogan et al. 1986). Therefore, the measured BAF were compared to the model result at 511 
birth (t=0) and for t=1 year. The calculated BAF milk are higher for t=0 and do not vary 512 
much, as all compounds are lipophilic with log KOW >4.7. The predicted BAF are 513 
somewhat too low, except for dieldrin and TCDD. The largest deviation is seen for PCB, 514 
which is not a single compound but a mix of 209 congeners. The averaged ratio between 515 
regression result and measured BAF is 2.02 (1.09 without TCDD). The ratio between 516 
model prediction and measurements is 0.99 (0.87 without TCDD) for t=0 and 0.42 (0.37 517 
without TCDD) for t=1 year.  518 
 519 
<Figure 6> <Figure 7>  520 
 521 
4.4 Comment on Nursing 522 
The question is often raised whether nursing may have an adverse impact on the health of 523 
the child (BgVV 2000). While the high dose of POPs (here: TCDD) that the infant 524 
receives with breast milk suggests so, the moderate increase of infant body concentration 525 
gives less reasons to be concerned. There is evidence that after a few life-years, the 526 
difference between breast-fed and formula-fed infants in their body-burden with POPs, 527 
such as TCDD, vanishes (Kreuzer et al. 1997). If the mother nurses more than one child 528 
without longer periods in between, the model predicts lower body-burdens for the later 529 
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children, i.e., for the second child after one year nursing, the body concentration is about 530 
the same as in the mother, if she never had breast-fed. Empirical studies confirm that the 531 
first born child is at higher risk to be exposed to POPs that have accumulated in mother 532 
and are transferred via mother milk (Tanabe and Kunisue 2007), and that levels of POPs 533 
decrease during lactation (Harris et al. 2001). An argument pro nursing may also be that 534 
the mother reduces her POP pool (Schecter et al. 1996). Metabolism in the body of the 535 
mother reduces the dose transferred to the nursing infant. With metabolism half-times 536 
below 14 days, the model predicts that the dose the nursing infant receives is always 537 
below the dose for the mother. According to the model, the mother has a "filter effect" for 538 
less lipophilic and volatile compounds: for those, the dose for the infant via breast milk is 539 
lower than the dose mother takes up (per kg bodyweight) (Figure 4).  540 
 541 
4.5 Limitations and Application Range of the New Model   542 
The new mother-child model is, due to the underlying equations for phase equilibrium, 543 
not valid for inorganic (Wuenschmann et al. 2008) and electrolytic organic compounds 544 
(Trapp 2004, Trapp and Horobin 2005). The assumption of phase equilibrium within the 545 
body for neutral lipophilic organic compounds is supported by the results of Kreuzer et 546 
al. (1997), who found comparable levels of TCDD in lipids of adipose tissue, feces, 547 
blood, liver, breast milk and new-borns. Deviations from equilibrium could in particular 548 
occur for compounds with rapid metabolism. However, for those the model predicts low 549 
transfer into infants anyhow, thus, a "false alarm" due to over-prediction would not occur, 550 
if accurate metabolism rate constants are at hand.  551 
 552 
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The new mother-child model is more complex than the regression of Travis et al. (1988), 553 
but still the structure is relatively easy, and the analytical solution of the differential 554 
equations keeps the calculations compact and robust. The model requires five chemical 555 
input parameters (iD, KOW, CA, KAW and kdeg). It may be more troublesome to acquire these 556 
data, but the differences in the accumulation behavior of persistent and reactive 557 
compounds can be considered, and uptake via diet and inhalation can be calculated 558 
simultaneously or separately. Therefore, results from diet studies can be used as input 559 
data, and bioaccumulation factors as defined by Travis et al. (1988) can be calculated, 560 
using iD =1 mg d-1 and CA =0. The regression necessarily will fail if uptake from air plays 561 
a major role. 562 
 563 
Another advantage of the deterministic approach, compared to empirical relations, is that 564 
the relevant processes behind the BAF can be identified. The variation of physiological 565 
parameters (for the human body) allows to determine the influence of age, diet, 566 
bodyweight, growth, metabolism etc. Furthermore, the regression violates the mass 567 
balance for more lipophilic compounds with high log KOW and gives unrealistically high 568 
BAF, as was shown before. 569 
 570 
In comparison to more sophisticated models for bioaccumulation (Kreuzer et al. 1997, 571 
Molen et al. 1996, Maruyama et al. 2003), the new mother-child model is more compact 572 
and more variable (i.e., it does not require the measurement of any chemical-specific 573 
data, besides the minimum data set, and it needs no calibration steps). Compared to the 574 
human bioaccumulation model ACC (Czub and McLachlan 2004b), which calculates the 575 
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body concentration of a single human over the whole life-time, the mother-child model is 576 
less complex and more flexible, due to the analytical solution. If, for the purpose of risk 577 
assessment, only the dose for the infant is required, the differential equation system is 578 
decoupled, and the solution for the breast-feeding mother alone can be solved (eq. 11). 579 
  580 
The development of the new mother-child model was driven by the need to predict the 581 
exposure of nursing children within the framework of chemical risk assessment and/or 582 
risk assessment of polluted sites. Model systems for these purposes exist (EC 1996, 583 
Rikken et al. 2001, Kulhanek et al. 2004) but none of them considers nursing infants (in 584 
fact, children are not considered at all in most of them). The new model could be added 585 
with small effort to existing exposure assessment tools, in order to fill this gap.  586 
 587 
Model availability  588 
The new mother-child model is available as unprotected excel-spreadsheet version from 589 
the first author. Please mail to stt@er.dtu.dk.     590 
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Table 1. Default input data for the mother-child model.  741 
Parameter Symbol Value  Unit Reference 
Mother      
Age  t 25 a Kreuzer et al. (1997) 
Body mass  MH 60 kg Maruyama et al. (2003) 
Body water fraction W 0.71 L/kg Czub and McLachlan (2004b) 
Body lipid fraction L 0.284 kg/kg  Deurenberg et al. (1991) 
Outflux of water  FW 1.24 L d-1 Maruyama et al. (2003) 
Outflux of lipid FL 0.007 kg d-1 10% of lipids in diet 
In/exhalation of air FA  11 m3 d-1 Layton (1993) 
Breast milk data     
Milk flux  FM  1 kg d-1 Kreuzer et al. (1997) 
Milk water content WM 0.87 L kg-1 Czub and McLachlan (2004b) 
Milk lipid content LM 0.045 kg kg-1 Kreuzer et al. (1997) 
Child     
Age t 0 - 3 a  
Body mass Mb 3.5 - 7.25  kg Hesse et al. (1997) 
Body water fraction  W 0.71 L/kg Czub and McLachlan (2004b) 
Body lipid fraction L 0.233 kg/kg  Deurenberg et al. (1991) 
Outflux of water  FW 0.87 L d-1 water content of 1 kg milk 
Outflux of lipid FL 0.0045 kg d-1 10% of influx 
Outflux of air FA  4.5 m3 d-1 Layton (1993) 
Other data     
Density of water W 1 kg L-1  
Density of lipids L 0.82 kg L-1  
Density of air A 1.3×10-3 kg L-1  
 742 
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Table 2. Names and physico-chemical data of the compounds in Travis et al. (1988).  743 
Abbreviation Compound log KOW   a KAW  b 
Benzene benzene 2.13 0.23 
DDE 1,1-bis(4-chlorphenyl)-2,2-dichlorethen 5.83 0.05 
DDT 1,1-bis(4-chlorphenyl)-2,2,2-trichlorethan 5.76 0.0016 
DCM dichlormethane 1.32 0.087 
Dieldrin dieldrin 5.16 0.0044 
HE heptachlor epoxide 5.40 0.01 
HCB hexachlorbenzene 5.45 0.028 
PCE perchlorethene 2.53 0.54 
PCB polychlorinated biphenyls 6.50 0.001 c 
TCE trichlorethene 2.33 0.35 
MC methylchloroform 2.47 0.715 
TCDD 2,3,7,8-tetrachlordibenzo-p-dioxin 6.76 b 0.0015 
a) Travis et al. (1988) if not given otherwise; b) Rippen (1991-2007) if not given otherwise;  744 
c) estimate; PCB is a mix of 209 compounds.  745 
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Figures to Coupled Mother-Child Model for Bioaccumulation of POPs in Nursing Infants 747 
 748 
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 750 
  751 
 752 
Figure Captions 753 
 754 
Figure 1. System overview  755 
 756 
Figure 2. Concentrations in nursing mother and child (ng kg-1 lipids) after uptake of 25 757 
pg TCDD per day with diet by the mother.  758 
 759 
 760 
Figure 3.  Ratio of the TCDD-dose taken up by the nursing infant (per kg bw) to the dose 761 
taken up by the mother (25 pg d-1 = 0.42 pg kg-1 bw d-1).  762 
 763 
Figure 4. Calculated bioaccumulation factor (BAF) mother (t=0) and milk (t=0.5 a) with 764 
varying log KOW for low KAW (KAW =10-9 L L-1) and high KAW (KAW =0.1 L L-1) compared 765 
to the result derived with the regression of Travis et al. (1988). 766 
 767 
Figure 5. Calculated ratio of uptake via inhalation to uptake via diet for the assumption 768 
of phase equilibrium for mother and child (t=0.5 a) with varying log KOW for high KAW 769 
(KAW =0.1 L L-1), moderate KAW (KAW =0.001 L L-1) and low KAW (KAW =10-6 L L-1). 770 
Dotted line shows ratio 1:1. 771 
 772 
 773 
Figure 6. Bioaccumulation factors (related to lipid content) for human adipose tissue for 774 
12 neutral organic compounds collected from literature (Lit) compared to the regression 775 
by Travis et al. (1988) and the model outcome for mother before birth at steady-state.  776 
 777 
Figure 7. Bioaccumulation factors (related to lipid content) for human milk for 7 neutral 778 
organic compounds collected from literature (Lit) compared to the regression by Travis et 779 
al. (1988) and the model outcome for t=0 (model t=0, at birth) and t=1 year (model t=1).  780 
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